Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2Tumor-Agnostic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Neoplasms 1Neoplasm Metastasis 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Sorafenib 110Temozolomide 109Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × fosbretabulin × Clear all
NCT00003768 2014-01-07

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Case Comprehensive Cancer Center

Phase 1 Completed
25 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003698 2013-12-19

Chemotherapy in Treating Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
35 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00395434 2011-10-31

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Mateon Therapeutics

Phase 1 Completed
20 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡